🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
2.380
-0.170 (-6.67%)
At close: Nov 20, 2026, 4:00 PM EST
2.419
+0.039 (1.65%)
After-hours: Nov 20, 2026, 4:23 PM EST

TNXP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
43.0513.1110.097.77--
Revenue Growth
317.96%29.85%29.94%---
Cost of Revenue
4.596.647.774.74--
Gross Profit
38.466.472.333.03--
Selling, General & Admin
145.8587.6840.134.7530.2223.47
Research & Development
80.444.4939.9786.6681.8868.84
Operating Expenses
226.25132.1780.07121.41112.0992.31
Operating Income
-187.79-125.7-77.74-118.38-112.09-92.31
Interest Expense
-0.09-0.09-1.23---
Interest & Investment Income
5.574.150.02--0.03
Other Non Operating Income (Expenses)
1.32-0.287.881.721.87-
EBT Excluding Unusual Items
-180.99-121.93-71.08-116.66-110.22-92.29
Impairment of Goodwill
---1---
Asset Writedown
---57.96---
Other Unusual Items
--2.09----
Pretax Income
-180.99-124.02-130.04-116.66-110.22-92.29
Net Income
-180.99-124.02-130.04-116.66-110.22-92.29
Preferred Dividends & Other Adjustments
----6.66-
Net Income to Common
-180.99-124.02-130.04-116.66-116.88-92.29
Net Income Growth
------
Shares Outstanding (Basic)
1591---
Shares Outstanding (Diluted)
1591---
Shares Change
148.03%1055.90%----
EPS (Basic)
-11.93-14.57-176.60---
EPS (Diluted)
-11.93-14.57-176.60---
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-170.04-103.21-61.05-109.9-146.2-110.86
Free Cash Flow Per Share
-11.21-12.13-82.90---
Gross Margin
89.33%49.34%23.07%38.97%--
Operating Margin
-436.25%-959.05%-770.20%-1523.94%--
Profit Margin
-420.45%-946.22%-1288.25%-1501.78%--
Free Cash Flow Margin
-395.02%-787.47%-604.76%-1414.75%--
EBITDA
-185.49-123.78-74.32-114.09-110.84-92.26
D&A For EBITDA
2.311.933.424.291.250.05
EBIT
-187.79-125.7-77.74-118.38-112.09-92.31
SEC Filings: 10-K · 10-Q